World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
37315
World Ranking
9223
National Ranking
4757

Overview

Bruce G. Haffty is affiliated with Rutgers, The State University of New Jersey in the United States. Their research work primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in cancer-related studies.

The main areas of study covered by Bruce G. Haffty include:

  • Cancer Research
  • Oncology
  • Radiology, Nuclear Medicine and Imaging
  • Surgery
  • Radiation

Their research topics focus on:

  • Breast Cancer Treatment Studies
  • Advanced Radiotherapy Techniques
  • Advances in Oncology and Radiotherapy
  • Breast Implant and Reconstruction
  • Breast Lesions and Carcinomas
  • Global Cancer Incidence and Screening
  • Cancer Diagnosis and Treatment

Bruce G. Haffty has published extensively in several prominent journals. The most frequent publication venues include:

  • International Journal of Radiation Oncology*Biology*Physics
  • Cancer Research
  • Journal of Clinical Oncology
  • Annals of Surgical Oncology
  • Advances in Radiation Oncology

Recent notable publications by Bruce G. Haffty include:

  • Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group, 2021, Radiotherapy and Oncology
  • Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee, 2021, International Journal of Radiation Oncology*Biology*Physics
  • Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis, 2021, The Lancet Oncology
  • Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression, 2020, Journal of Clinical Investigation
  • Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA, 2023, Journal of Clinical Oncology

Frequent co-authors collaborating with Bruce G. Haffty include:

  • Nisha Ohri
  • Mutlay Sayan
  • Shicha Kumar
  • Zeinab Abou Yehia
  • Deborah Toppmeyer

Best Publications

  • Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial

    Judy C. Boughey;Vera J. Suman;Elizabeth A. Mittendorf;Gretchen M. Ahrendt

  • Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

    Bruce G. Haffty;Qifeng Yang;Michael Reiss;Thomas Kearney

  • Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).

    Benjamin D. Smith;Benjamin D. Smith;Douglas W. Arthur;Thomas A. Buchholz;Bruce G. Haffty

  • 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers

    Peter Bouwman;Amal Mahmoud Aly;Jose M. Escandell;Mark Pieterse

  • Molecular Classification Identifies a Subset of Human Papillomavirus–Associated Oropharyngeal Cancers With Favorable Prognosis

    Paul M. Weinberger;Ziwei Yu;Bruce G. Haffty;Diane Kowalski

  • Postoperative Radiotherapy for Stage II or III Non–Small-Cell Lung Cancer Using the Surveillance, Epidemiology, and End Results Database

    Brian E. Lally;Daniel Zelterman;Joseph M. Colasanto;Bruce G. Haffty

  • Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline.

    Benjamin D. Smith;Jennifer R. Bellon;Rachel Blitzblau;Gary Freedman

  • VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors

    Xin Lu;Euphemia Mu;Yong Wei;Sabine Riethdorf

  • MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer

    Guohong Hu;Robert A. Chong;Qifeng Yang;Yong Wei

  • Fractionation for Whole Breast Irradiation: An American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline

    Benjamin D. Smith;Soren M. Bentzen;Candace R. Correa;Carol A. Hahn

  • Insulin-like Growth Factor-I Receptor Overexpression Mediates Cellular Radioresistance and Local Breast Cancer Recurrence after Lumpectomy and Radiation

    Bruce C. Turner;Bruce G. Haffty;Latha Narayanan;Jianling Yuan

  • Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast.

    L. J. Solin;J. Kurtz;A. Fourquet;R. Amalric

  • True recurrence vs. new primary ipsilateral breast tumor relapse : An analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management

    Tanya E Smith;Daesung Lee;Bruce C Turner;Darryl Carter

  • Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial

    Reshma Jagsi;Manjeet Chadha;Janaki Moni;Janaki Moni;Karla Ballman

  • Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy in BRCA1/2-Associated Stage I/II Breast Cancer

    Lori J. Pierce;Albert M. Levin;Timothy R. Rebbeck;Merav A. Ben-David

  • Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status

    Bruce G Haffty;Elizabeth Harrold;Atif J Khan;Pradip Pathare

  • Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma.

    Benjamin D. Smith;Grace L. Smith;Darryl Carter;Clarence T. Sasaki

  • Elf5 inhibits the epithelial–mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2

    Rumela Chakrabarti;Rumela Chakrabarti;Julie Hwang;Mario Andres Blanco;Yong Wei

  • Radiation-Induced Heart Disease: Pathologic Abnormalities and Putative Mechanisms

    Neil K. Taunk;Bruce G. Haffty;John B. Kostis;Sharad Goyal

  • Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer

    B.G. Haffty

Frequent Co-Authors

Qifeng Yang
Qifeng Yang Shandong University
Frank A. Vicini
Frank A. Vicini Beaumont Health
Thomas A. Buchholz
Thomas A. Buchholz The University of Texas MD Anderson Cancer Center
Henry Mark Kuerer
Henry Mark Kuerer The University of Texas MD Anderson Cancer Center
David L. Rimm
David L. Rimm Yale University
Lori J. Pierce
Lori J. Pierce University of Michigan–Ann Arbor
Reshma Jagsi
Reshma Jagsi University of Michigan–Ann Arbor
Judy C. Boughey
Judy C. Boughey Mayo Clinic
Peter M. Glazer
Peter M. Glazer Yale University
Karla V. Ballman
Karla V. Ballman Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring a future in medicine but open to alternative or supporting healthcare careers, there are many online degree options to consider. Many students start by researching whats the easiest nursing program to get into? as nursing remains a high-demand profession with flexible entry routes. Some nursing schools that don't require teas or hesi exams can make the application process less stressful for prospective students.

For those interested in the administrative side of healthcare, online health administration programs offer accelerated options to help you transition into leadership and management roles. Alternatively, students can also look into medical coding and billing classes online with financial aid to start a career in healthcare data and insurance processing. Each of these pathways provides different routes to enter the healthcare field, offering flexibility and opportunities for advancement, even if medical school is not your chosen path.

Best Scientists Citing Bruce G. Haffty

Trending Scientists

Recently Published Articles